Advertisement

Topics

ZappRx Company Profile

13:16 EDT 19th July 2018 | BioPortfolio

ZappRx simplifies the complex process required to order specialty medications, making it easier to collect and save all of the information required to order a prescription — including pharmacy information, payer/prior authorization requirements, and relevant patient clinical history. ZappRx then enables providers, pharmacists, and payers to digitally interact with one another to fill a prescription, reducing the need for fax and phone call interactions. The platform is currently live in three disease areas, including Pulmonary Arterial Hypertension (PAH), Idiopathic Pulmonary Fibrosis (IPF), and Cystic Fibrosis, with plans to expand to support prescribing in other therapeutic areas, including gastroenterology, rheumatology, and neurology.


News Articles [5 Associated News Articles listed on BioPortfolio]

ZappRx Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

HITRUST CSF Certification validates ZappRx is committed to meeting key regulations and protecting sensitive information ZappRx, a leading healthcare technology company that re...

ZappRx to Showcase Product at Pulmonary Hypertension Association (PHA) International Conference | Booth #507

Specialty prescribing and prior authorization technology leader announces significant momentum at renowned industry event, including notable customer wins and product updates ...

ZappRx Announces Integration with FDB MedsTracker® eRx at Asembia 2018 Specialty Pharmacy Summit

Collaboration empowers healthcare providers with easy access to patient drug history and mission critical information about the medications prescribed on the ZappRx platform ...

ZappRx Expanding Partnership with PARx Solutions as Part of Their Growth into New Treatment Areas

Collaboration improves quality of care and empowers healthcare providers across multiple specialties with streamlined, digital prescribing and prior authorization ZappR...

Lorrie A. Carr Appointed as CEO for Excelera

Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2. She assumed her responsibilities on July 9th. MINNEAPOLIS (PRWEB) July...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

ZappRx

ZappRx simplifies the complex process required to order specialty medications, making it easier to collect and save all of the information required to order a prescription — ...

More Information about "ZappRx" on BioPortfolio

We have published hundreds of ZappRx news stories on BioPortfolio along with dozens of ZappRx Clinical Trials and PubMed Articles about ZappRx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ZappRx Companies in our database. You can also find out about relevant ZappRx Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record